Top Section/Ad
Top Section/Ad
Most recent
Even leveraged deals still being underwritten, though banks are selective
Liquidity event at American manager comes at fraught time for industry
Major sectors in leveraged loans are trading down, making shrewd credit selection vital
Deal could include $950m of bonds
More articles/Ad
More articles/Ad
More articles
-
Paediatric nutrition company Biostime has signed up one lender to arrange a $450m take out of a bridge loan raised last year for the acquisition of Swisse Wellness. -
A senior banker in charge of structured loans at Hang Seng Bank is set to leave after more than a decade, according to sources.
-
PQ Corp, the US inorganic chemicals producer, and Inovyn, the UK-headquartered chorvinyls producer — both partly owned by Ineos, the petrochemicals company — are marketing over $2bn of refinancing debt over the coming days.
-
Two privately owned Indonesian companies have hit the loan market with attractive margins on offer, marking a break from thinly priced deals by state-owned firms. But the mood among bankers is one of caution. While the outcome will provide a clear picture of the appetite for Indonesia, the syndications will face challenges. Shruti Chaturvedi reports.
-
The leveraged loan market in Europe is close to a standstill. Only two deals launched this week, Solenis' €100m incremental term loan ‘B’ and PQ's $300m equivalent term loan 'B', and bankers said there is little more notable issuance to come.
-
Panama’s Global Bank eyes Asia liquidity — Indo Eximbank in $725m fundraising — Protelindo in bilateral talks
